The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner. 2016

Grace E Richmond, and Laura P Evans, and Michele J Anderson, and Matthew E Wand, and Laura C Bonney, and Alasdair Ivens, and Kim Lee Chua, and Mark A Webber, and J Mark Sutton, and Marnie L Peterson, and Laura J V Piddock
Antimicrobial Agents Research Group, Institute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham, United Kingdom.

The opportunistic pathogen Acinetobacter baumannii is able to persist in the environment and is often multidrug resistant (MDR), causing difficulties in the treatment of infections. Here, we show that the two-component system AdeRS, which regulates the production of the AdeABC multidrug resistance efflux pump, is required for the formation of a protective biofilm in an ex vivo porcine mucosal model, which mimics a natural infection of the human epithelium. Interestingly, deletion of adeB impacted only on the ability of strain AYE to form a biofilm on plastic and only on the virulence of strain Singapore 1 for Galleria mellonella RNA-Seq revealed that loss of AdeRS or AdeB significantly altered the transcriptional landscape, resulting in the changed expression of many genes, notably those associated with antimicrobial resistance and virulence interactions. For example, A. baumannii lacking AdeRS displayed decreased expression of adeABC, pil genes, com genes, and a pgaC-like gene, whereas loss of AdeB resulted in increased expression of pil and com genes and decreased expression of ferric acinetobactin transport system genes. These data define the scope of AdeRS-mediated regulation, show that changes in the production of AdeABC mediate important phenotypes controlled by AdeRS, and suggest that AdeABC is a viable target for antimicrobial drug and antibiofilm discovery [corrected].

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000151 Acinetobacter Infections Infections with bacteria of the genus ACINETOBACTER. Mimae Infections,Infections, Acinetobacter,Infections, Mimae,Acinetobacter Infection,Infection, Acinetobacter,Infection, Mimae,Mimae Infection
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity
D015964 Gene Expression Regulation, Bacterial Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria. Bacterial Gene Expression Regulation,Regulation of Gene Expression, Bacterial,Regulation, Gene Expression, Bacterial
D018441 Biofilms Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents. Biofilm
D024901 Drug Resistance, Multiple, Bacterial The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Drug Resistance, Extensive, Bacterial,Drug Resistance, Extensively, Bacterial,Extensive Antibacterial Drug Resistance,Extensively Antibacterial Drug Resistance,Multidrug Resistance, Bacterial,Multiple Antibacterial Drug Resistance,Bacterial Multidrug Resistance,Bacterial Multidrug Resistances,Resistance, Bacterial Multidrug
D026901 Membrane Transport Proteins Membrane proteins whose primary function is to facilitate the transport of molecules across a biological membrane. Included in this broad category are proteins involved in active transport (BIOLOGICAL TRANSPORT, ACTIVE), facilitated transport and ION CHANNELS. Biological Pump,Membrane Transport Protein,Membrane Transporter,Membrane Transporters,Metabolic Pump,Permease,Biological Pumps,Metabolic Pumps,Permeases,Pump, Biologic,Pump, Biological,Pump, Metabolic,Pumps, Biological,Pumps, Metabolic,Biologic Pump,Protein, Membrane Transport,Transport Protein, Membrane,Transport Proteins, Membrane,Transporter, Membrane,Transporters, Membrane

Related Publications

Grace E Richmond, and Laura P Evans, and Michele J Anderson, and Matthew E Wand, and Laura C Bonney, and Alasdair Ivens, and Kim Lee Chua, and Mark A Webber, and J Mark Sutton, and Marnie L Peterson, and Laura J V Piddock
December 2017, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Grace E Richmond, and Laura P Evans, and Michele J Anderson, and Matthew E Wand, and Laura C Bonney, and Alasdair Ivens, and Kim Lee Chua, and Mark A Webber, and J Mark Sutton, and Marnie L Peterson, and Laura J V Piddock
December 2021, mSphere,
Grace E Richmond, and Laura P Evans, and Michele J Anderson, and Matthew E Wand, and Laura C Bonney, and Alasdair Ivens, and Kim Lee Chua, and Mark A Webber, and J Mark Sutton, and Marnie L Peterson, and Laura J V Piddock
September 2004, Antimicrobial agents and chemotherapy,
Grace E Richmond, and Laura P Evans, and Michele J Anderson, and Matthew E Wand, and Laura C Bonney, and Alasdair Ivens, and Kim Lee Chua, and Mark A Webber, and J Mark Sutton, and Marnie L Peterson, and Laura J V Piddock
January 2018, Frontiers in cellular and infection microbiology,
Grace E Richmond, and Laura P Evans, and Michele J Anderson, and Matthew E Wand, and Laura C Bonney, and Alasdair Ivens, and Kim Lee Chua, and Mark A Webber, and J Mark Sutton, and Marnie L Peterson, and Laura J V Piddock
March 2021, Journal of bacteriology,
Grace E Richmond, and Laura P Evans, and Michele J Anderson, and Matthew E Wand, and Laura C Bonney, and Alasdair Ivens, and Kim Lee Chua, and Mark A Webber, and J Mark Sutton, and Marnie L Peterson, and Laura J V Piddock
February 2017, Journal of bacteriology,
Grace E Richmond, and Laura P Evans, and Michele J Anderson, and Matthew E Wand, and Laura C Bonney, and Alasdair Ivens, and Kim Lee Chua, and Mark A Webber, and J Mark Sutton, and Marnie L Peterson, and Laura J V Piddock
July 2015, Current microbiology,
Grace E Richmond, and Laura P Evans, and Michele J Anderson, and Matthew E Wand, and Laura C Bonney, and Alasdair Ivens, and Kim Lee Chua, and Mark A Webber, and J Mark Sutton, and Marnie L Peterson, and Laura J V Piddock
October 2023, The Indian journal of medical research,
Grace E Richmond, and Laura P Evans, and Michele J Anderson, and Matthew E Wand, and Laura C Bonney, and Alasdair Ivens, and Kim Lee Chua, and Mark A Webber, and J Mark Sutton, and Marnie L Peterson, and Laura J V Piddock
November 2008, Microbiology (Reading, England),
Grace E Richmond, and Laura P Evans, and Michele J Anderson, and Matthew E Wand, and Laura C Bonney, and Alasdair Ivens, and Kim Lee Chua, and Mark A Webber, and J Mark Sutton, and Marnie L Peterson, and Laura J V Piddock
January 2019, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale,
Copied contents to your clipboard!